Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Enzymatic formation of compound-K from ginsenoside Rb1 by enzyme preparation from cultured mycelia of Armillaria mellea

  • Upadhyaya, Jitendra (Department of Food Science and Technology, Chonbuk National University) ;
  • Kim, Min-Ji (Department of Food Science and Technology, Chonbuk National University) ;
  • Kim, Young-Hoi (Department of Food Science and Technology, Chonbuk National University) ;
  • Ko, Sung-Ryong (Bureau of General Affairs, The Korean Society of Ginseng) ;
  • Park, Hee-Won (Korea Ginseng Corporation Research Institute, Korea Ginseng Corporation) ;
  • Kim, Myung-Kon (Department of Food Science and Technology, Chonbuk National University)
  • Received : 2015.04.01
  • Accepted : 2015.05.21
  • Published : 2016.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Minor saponins or human intestinal bacterial metabolites, such as ginsenosides Rg3, F2, Rh2, and compound K, are more pharmacologically active than major saponins, such as ginsenosides Rb1, Rb2, and Rc. In this work, enzymatic hydrolysis of ginsenoside Rb1 was studied using enzyme preparations from cultured mycelia of mushrooms. Methods: Mycelia of Armillaria mellea, Ganoderma lucidum, Phellinus linteus, Elfvingia applanata, and Pleurotus ostreatus were cultivated in liquid media at $25^{\circ}C$ for 2 wk. Enzyme preparations from cultured mycelia of five mushrooms were obtained by mycelia separation from cultured broth, enzyme extraction, ammonium sulfate (30-80%) precipitation, dialysis, and freeze drying, respectively. The enzyme preparations were used for enzymatic hydrolysis of ginsenoside Rb1. Results: Among the mushrooms used in this study, the enzyme preparation from cultured mycelia of A. mellea (AMMEP) was found to convert ginsenoside Rb1 into compound K with a high yield, while those from G. lucidum, P. linteus, E. applanata, and P. ostreatus produced remarkable amounts of ginsenoside Rd from ginsenoside Rb1. The enzymatic hydrolysis pathway of ginsenoside Rb1 by AMMEP was $Rb1{\rightarrow}Rd{\rightarrow}F2{\rightarrow}$ compound K. The optimum reaction conditions for compound K formation from ginsenoside Rb1 were as follows: reaction time 72-96 h, pH 4.0-4.5, and temperature $45-55^{\circ}C$. Conclusion: AMMEP can be used to produce the human intestinal bacterial metabolite, compound K, from ginsenoside Rb1 with a high yield and without food safety issues.

Keywords

References

  1. Christensene LP. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 2009;55:1-99.
  2. Liu CY, Song JG, Li PF, Yu HS, Jin FX. Ginsenoside contents in three different ginseng. J Dalian Polytechnic Univ 2011;30:79-82.
  3. Xu QF, Fang XL, Chen DF. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J Ethnopharmacol 2005;84:187-92.
  4. Yu K, Chen F, Li C. Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more? Curr Drug Metab 2012;13:577-98. https://doi.org/10.2174/1389200211209050577
  5. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004;95:153-7. https://doi.org/10.1254/jphs.FMJ04001X4
  6. Kato T, Kida T, Kanaoka M, Hattori M, Kobashi K. Drug metabolism: intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol 1998;50:1155-60. https://doi.org/10.1111/j.2042-7158.1998.tb03327.x
  7. Lee BH, Lee SJ, Hui JH, Lee SY, Sung JH, Huh JD, Moon CK. In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria. Planta Med 1998;64:500-3. https://doi.org/10.1055/s-2006-957501
  8. Bae EA, Choo MK, Park SY, Shin SY, Kim DH. Metabolism of ginsenoside Rc by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 2002;25:743-7. https://doi.org/10.1248/bpb.25.743
  9. Nag SA, Qin JJ, Wang W, Wang MH, Wang H, Zhang R. Ginsenosides as anticancer agents: in vitro and in vivo activities, structureeactivity relationships, and molecular mechanisms of action. Front Pharmacol 2012;3:1-18.
  10. Li HU, Bae EA, Han MJ, Kim DH. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury. Liver Int 2005;25:1069-73. https://doi.org/10.1111/j.1478-3231.2005.01068.x
  11. Park JS, Shin JA, Jung JS, Hyun JW, Van Le TKV, Kim DH, Park EM, Kim HS. Antiinflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice. J Pharmacol Exp 2012;341:59-67. https://doi.org/10.1124/jpet.111.189035
  12. Han BH, Park MH, Han YN, Woo LK, Sankawa U, Yahara S, Tanaka O. Degradation of ginseng saponins under mild acid condition. Planta Med 1982;44:146-9. https://doi.org/10.1055/s-2007-971425
  13. Chen YJ, Nose M, Ogihara Y. Alkaline cleavage of ginsenosides. Chem Pharm Bull 1987;35:1653-5. https://doi.org/10.1248/cpb.35.1653
  14. Yang XD, Yang YU, Ouyang DS, Yang GP. A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia 2015;100:208-20. https://doi.org/10.1016/j.fitote.2014.11.019
  15. Faber K. Advantages and disadvantages of biocatalysts. In: Biotransformation in organic chemistry. 3rd ed. Berlin: Springer-Verlag; 1997.
  16. Bae SH, Lee HS, Kim MR, Kim SY, Kim JM, Suh HJ. Changes of ginsenoside content by mushroom mycelial fermentation in red ginseng extract. J Ginseng Res 2011;35:235-42. https://doi.org/10.5142/jgr.2011.35.2.235
  17. Ryu JS, Lee HJ, Bae SH, Kim SY, Park YH, Suh HJ. The bioavailability of red ginseng extract of fermented by Phellinus linteus. J Ginseng Res 2013;37:108-16. https://doi.org/10.5142/jgr.2013.37.108
  18. By Hsu, Lu TJ, Chen CH, Wang SJ, Hwang LS. Biotransformation of ginsenoside Rd in the ginseng extraction residue by fermentation with lingzhi (Ganoderma lucidum). Food Chem 2013;141:4186-93. https://doi.org/10.1016/j.foodchem.2013.06.134
  19. Gao LW, Li WY, Zhao YL, Wang JW. The cultivation, bioactive components and pharmacological effects of Armillaria mellea. Afr J Biotechnol 2009;8:7383-440.
  20. Lung MY, Chang YC. Antioxidant properties of the edible basidiomycete Armillaria mellea in submerged cultures. Int J Mol Sci 2011;12:6367-84. https://doi.org/10.3390/ijms12106367
  21. Chen YJ, Wue SY, Chen CC, Tsaog YL, Hsu NC, Chou YC, Huang HL. Armillaria mellea component armillarikin induces apoptosis in human leukemia cells. J Funct Foods 2014;6:196-204. https://doi.org/10.1016/j.jff.2013.10.007
  22. Sanada S, Kondo N, Shoji J, Tanaka O, Shibata S. Studies on the saponins of ginseng. I. Structures of ginsenoside-Ro, -Rb1, -Rb2, -Rc, and -Rd. Chem Pharm Bull 1974;22:421-8. https://doi.org/10.1248/cpb.22.421
  23. Buswell JA, Cai YJ, Chang ST, Peberdy JF, Fu SY, Yu HS. Lignocellulolytic enzyme profiles of edible mushroom fungi. World J Microbiol Biotechnol 1996;12:537-42. https://doi.org/10.1007/BF00419469
  24. Baldrian P, Valaskova V. Degradation of cellulose by basiomycetous fungi. FEBS Microbiol Rev 2008;32:501-21. https://doi.org/10.1111/j.1574-6976.2008.00106.x
  25. Mfombep PM, Senwo ZN, Isikhuemhen OS. Enzymatic activities and kinetic properties of ${\beta}$-glucosidase from selected white rot fungi. Adv Biol Chem 2013;3:198-207. https://doi.org/10.4236/abc.2013.32025
  26. Sun BS, Xu MY, Li Z, Wang BW, Sung CK. UPLC-Q-TOF-MS/MS analysis for steaming times-dependent profiling of steamed Panax quinquefolius and its ginsenosides transformations induced by repetitious steaming. J Ginseng Res 2012;36:277-90. https://doi.org/10.5142/jgr.2012.36.3.277
  27. Luan H, Liu X, Qi X, Hu Y, Hao D, Cui Y, Yang L. Purification and haracterization of a novel stable ginsenoside Rb1-hydrolyzing ${\beta}$-D-glucosidase from China white jade snail. Process Biochem 2006;41:1974-80. https://doi.org/10.1016/j.procbio.2006.04.011
  28. Zhao X, Gao L, Wang J, Bi H, Gao J, Du X, Zhou Y, Tai G. A novel ginsenoside Rb1-hydrolyzing ${\beta}$-D-glucosidase from Cladosporium fulvum. Process Biochem 2009;44:612-8. https://doi.org/10.1016/j.procbio.2009.01.016
  29. Park CS, Yoo MH, Noh KH, Oh DK. Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases. Appl Microbiol Biotechnol 2010;87:9-19. https://doi.org/10.1007/s00253-010-2567-6
  30. Quan LH, Cheng LQ, Kim HB, Kim JH, Son NR, Kim SY, Jin HO, Yang DC. Bioconversion of ginsenoside Rd into compound K by Lactobacillus pentosus DC101 isolated from Kimchi. J Ginseng Res 2010;34:288-95. https://doi.org/10.5142/jgr.2010.34.4.288
  31. Zhou W, Yan Q, Li JY, Zhang XC, Zhou P. Biotransformation of Panax notoginseng saponins into ginsenoside compound K production by Paecilomyces bainier sp. 229. J Appl Microbiol 2008;104:699-706. https://doi.org/10.1111/j.1365-2672.2007.03586.x
  32. Park SY, Bae EA, Sung JH, Lee SK, Kim DH. Purification and characterization of ginsenoside Rb1-metabolizing beta-glucosidase from Fusobacterium K-60, a human intestinal anaerobic bacterium. Biosci Biotechnol Biochem 2001;65:1163-9. https://doi.org/10.1271/bbb.65.1163

Cited by

  1. Purification and characterization of a novel ginsenoside Rc-hydrolyzing β-glucosidase from Armillaria mellea mycelia vol.6, pp.None, 2016, https://doi.org/10.1186/s13568-016-0277-x
  2. Lactobacillus plantarum을 이용한 산양삼 추출물의 진세노사이드 Rg1 및 Rg5의 함량 증대 vol.45, pp.4, 2016, https://doi.org/10.4014/mbl.1711.11001
  3. Optimization of Fermentation Process Parameters for Ginsenoside Re Bioconversion by Plackett-Burman and Box-Benhnken Design vol.238, pp.None, 2016, https://doi.org/10.1051/matecconf/201823804001
  4. Production of Minor Ginenosides from Panax notoginseng by Microwave Processing Method and Evaluation of Their Blood-Enriching and Hemostatic Activity vol.23, pp.6, 2018, https://doi.org/10.3390/molecules23061243
  5. PEGylation of Ginsenoside Rg3-Entrapped Bovine Serum Albumin Nanoparticles: Preparation, Characterization, and In Vitro Biological Studies vol.2019, pp.None, 2016, https://doi.org/10.1155/2019/3959037
  6. Accelerated and Severe Lupus Nephritis Benefits From M1, an Active Metabolite of Ginsenoside, by Regulating NLRP3 Inflammasome and T Cell Functions in Mice vol.10, pp.None, 2016, https://doi.org/10.3389/fimmu.2019.01951
  7. Biotransformation of Glycoginsenosides to Intermediate Products and Aglycones using a Hemicellulosome Produced by Cellulosimicrobium cellulan vol.55, pp.2, 2019, https://doi.org/10.1134/s0003683819020054
  8. New perspective on the metabolism of AD-1 in vivo: Characterization of a series of dammarane-type derivatives with novel metabolic sites and anticancer mechanisms of active oleanane-type metabolites vol.88, pp.None, 2016, https://doi.org/10.1016/j.bioorg.2019.102961
  9. Cooperated biotransformation of ginsenoside extracts into ginsenoside 20(S)‐Rg3 by three thermostable glycosidases vol.128, pp.3, 2020, https://doi.org/10.1111/jam.14513
  10. Biocatalytic strategies for the production of ginsenosides using glycosidase: current state and perspectives vol.104, pp.9, 2016, https://doi.org/10.1007/s00253-020-10455-9
  11. Ginsenoside Compound K: Insights into Recent Studies on Pharmacokinetics and Health-Promoting Activities vol.10, pp.7, 2016, https://doi.org/10.3390/biom10071028
  12. IgA Nephropathy Benefits from Compound K Treatment by Inhibiting NF-κB/NLRP3 Inflammasome and Enhancing Autophagy and SIRT1 vol.205, pp.1, 2016, https://doi.org/10.4049/jimmunol.1900284
  13. A new 3,4-seco-lupane triterpenene glycosyl ester from the leaves of Eleutherococcus sessiliflorus vol.34, pp.13, 2016, https://doi.org/10.1080/14786419.2018.1564292
  14. One-Pot Process for the Production of Ginsenoside Rd by Coupling Enzyme-Assisted Extraction with Selective Enzymolysis vol.43, pp.10, 2016, https://doi.org/10.1248/bpb.b19-01127
  15. Biotransformation of Protopanaxadiol-Type Ginsenosides in Korean Ginseng Extract into Food-Available Compound K by an Extracellular Enzyme from Aspergillus niger vol.30, pp.10, 2016, https://doi.org/10.4014/jmb.2007.07003
  16. Complete Bioconversion of Protopanaxadiol-Type Ginsenosides to Compound K by Extracellular Enzymes from the Isolated Strain Aspergillus tubingensis vol.69, pp.1, 2021, https://doi.org/10.1021/acs.jafc.0c07424
  17. Antioxidant, Anti-Inflammatory and Antithrombotic Effects of Ginsenoside Compound K Enriched Extract Derived from Ginseng Sprouts vol.26, pp.13, 2021, https://doi.org/10.3390/molecules26134102
  18. An enzyme immobilized microreactor for continuous‐flow biocatalysis of ginsenoside Rb1 vol.96, pp.12, 2016, https://doi.org/10.1002/jctb.6887
  19. Ginsenoside Compound K Assisted G-Quadruplex Folding and Regulated G-Quadruplex-Containing Transcription vol.26, pp.23, 2016, https://doi.org/10.3390/molecules26237339